Experimental animal models of HIV/AIDS for vaccine trials

Bioprinting covers the precise deposition of cells, biological scaffolds and growth factors to
produce desired tissue models. The main focus of bioprinting is the creation of functional …

被引用次数：48 相关文章所有 3 个版本

The complex challenges of HIV vaccine development require renewed and expanded global commitment

LG Bekker, R Tatoud, F Dabis, M Feinberg, P Kaleebu… - The Lancet, 2020 - thelancet.com

Despite substantial progress in understanding and treating HIV/AIDS, existing tools have not
effectively controlled the epidemic, and the potential threat of resurgence looms as the …

被引用次数：54 相关文章所有 8 个版本

[HTML] springer.com Full View

[HTML][HTML] Inhibition of caspase pathways limits CD4⁺ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid …

AJ Holloway, TB Saito, KF Naqvi, MB Huante, X Fan… - Retrovirology, 2024 - Springer

The study of HIV infection and pathogenicity in physical reservoirs requires a biologically
relevant model. The human immune system (HIS) mouse is an established model of HIV …

Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate

L Sadeghi, A Bolhassani, E Mohit, K Baesi… - Microbial …, 2024 - Elsevier

Bacteria-derived outer membrane vesicles (OMVs) can be engineered to incorporate foreign
antigens. This study explored the potential of ClearColi™-derived OMVs as a natural …

3D Printable Gel-Inks for Microbes and Microbial Structures

E Saygili, MS Draz - 3D printable Gel-inks for Tissue Engineering …, 2021 - Springer

Bioprinting and the precise engineering of cells, biological material, and structures into
multidimensional tissue models are the most rapidly growing research areas in biology and …